CALC
No price yet
Announcements
Nothing here yet
Daily updates
Nothing here yet
FDA designations
Nothing here yet
News
- CalciMedica aligns with FDA on Phase 2b trial design for Auxora in acute pancreatitisJul 29, 2026
- CalciMedica reported that Auxora may continue clinical development following FDA review of interim KOURAGE safety dataJun 24, 2026
- CalciMedica discontinued Phase 2 KOURAGE trial in AKI per DMC recommendationJan 28, 2026
- CalciMedica publishes preclinical JCI Insight data supporting a CRAC channel inhibitor as a potential therapy for pulmonary arterial hypertensionNov 12, 2025